Bernhard Lämmle

19.0k total citations · 1 hit paper
288 papers, 12.6k citations indexed

About

Bernhard Lämmle is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Bernhard Lämmle has authored 288 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Hematology, 128 papers in Immunology and 89 papers in Genetics. Recurrent topics in Bernhard Lämmle's work include Complement system in diseases (111 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (68 papers) and Platelet Disorders and Treatments (63 papers). Bernhard Lämmle is often cited by papers focused on Complement system in diseases (111 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (68 papers) and Platelet Disorders and Treatments (63 papers). Bernhard Lämmle collaborates with scholars based in Switzerland, Germany and United States. Bernhard Lämmle's co-authors include Johanna A. Kremer Hovinga, Miha Furlan, Rodolfo Robles, James N. George, Sara K. Vesely, Lorenzo Alberio, Max Solenthaler, Deirdra R. Terrell, Walter A. Wuillemin and M Furlan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Bernhard Lämmle

280 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations I. Scharrer, Bernhard Lämmle et al. profile →

Peers

Countries citing papers authored by Bernhard Lämmle

Since Specialization

Citations

This map shows the geographic impact of Bernhard Lämmle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Lämmle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Lämmle more than expected).

Fields of papers citing papers by Bernhard Lämmle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Lämmle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Lämmle. The network helps show where Bernhard Lämmle may publish in the future.

Co-authorship network of co-authors of Bernhard Lämmle

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Lämmle. A scholar is included among the top collaborators of Bernhard Lämmle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Lämmle. Bernhard Lämmle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency–causing KNG1 variants, and estimated prevalence 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Stefano Barco, Alice Trinchero, (unknown), (unknown), Chiara Ambaglio, Vincenzo Rocco, (unknown), Luigi Tomao, Arlette Ruiz‐Sàez, (unknown), Sonja Alesci, (unknown), (unknown), Friederike Häuser, Karl J. Lackner, Bernhard Lämmle, Heidi Rossmann	7
2	Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations? 2023 ·International Journal of Molecular Sciences ·Friederike Häuser, Heidi Rossmann, (unknown), (unknown), (unknown), Claudia Paret, Jörg Faber, Karl J. Lackner, Bernhard Lämmle, Olaf Beck	5
3	Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura 2021 ·Blood ·(unknown), Lukas Bütikofer, Kenneth D. Friedman, James N. George, Ingrid Hrachovinová, Paul Knöbl, Masanori Matsumoto, (unknown), (unknown), (unknown), (unknown), Katarzyna Aleksandra Jalowiec, Carlo R. Largiadèr, Zoltán Prohászka, György Sinkovits, Jerzy Windyga, Bernhard Lämmle, Johanna A. Kremer Hovinga	41
4	Redefining outcomes in immune TTP: an international working group consensus report 2021 ·Blood ·Adam Cuker, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, (unknown), Paul Knoebl, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, Flora Peyvandi, Kazuya Sakai, Ravi Sarode, (unknown), Yoshiaki Tomiyama, Agnès Veyradier, John‐Paul Westwood, Marie Scully	121
5	c.451dupT in KLKB1 is common in Nigerians, confirming a higher prevalence of severe prekallikrein deficiency in Africans compared to Europeans 2020 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), Stefano Barco, Alice Trinchero, Dagmar Laubert‐Reh, Konstantin Strauch, Philipp S. Wild, Karl J. Lackner, Bernhard Lämmle, Heidi Rossmann	0
6	Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence 2020 ·Journal of Thrombosis and Haemostasis ·Stefano Barco, (unknown), Alice Trinchero, (unknown), Hassan Abolghasemi, Laura Conti, Friederike Häuser, Johanna A. Kremer Hovinga, Karl J. Lackner, (unknown), (unknown), (unknown), Luigi Tomao, Walter A. Wuillemin, Barbara Zieger, Bernhard Lämmle, Heidi Rossmann	17
7	Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura 2017 ·Transfusion ·Tanja Falter, (unknown), (unknown), Veronika Weyer, Charis von Auer, Stefanie Wagner, Gudrun Hefner, Manfred E. Beutel, Karl J. Lackner, Bernhard Lämmle, I. Scharrer	40
8	Thromboembolism in patients with congenital afibrinogenaemia 2016 ·Thrombosis and Haemostasis ·Michael Nagler, Lorenzo Alberio, (unknown), Hendrik von Tengg‐Kobligk, Daniel Lottaz, Marguerite Neerman‐Arbez, Bernhard Lämmle, Johanna A. Kremer Hovinga	31
9	Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies 2014 ·Journal of Thrombosis and Haemostasis ·Miguel Jiménez-Alcázar, Markus Napirei, Rachita Panda, (unknown), Johanna A. Kremer Hovinga, Hans Georg Mannherz, Sven Peine, Thomas Renné, Bernhard Lämmle, Tobias A. Fuchs	114
10	Plasma DNA is elevated in patients with deep vein thrombosis 2013 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·José A. Díaz, Tobias A. Fuchs, (unknown), Johanna A. Kremer Hovinga, Bernhard Lämmle, Peter K. Henke, Daniel D. Myers, Denisa D. Wagner, Thomas W. Wakefield	113
11	Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura 2012 ·Hematology ·Johanna A. Kremer Hovinga, Bernhard Lämmle	55
12	Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura 2011 ·Haematologica ·(unknown), JN George, Sara K. Vesely, Deirdra R. Terrell, Khatira Aboulfatova, Jing Dong, Brenda M. Luken, Jan Voorberg, Ulrich Budde, Irmela Sulzer, Bernhard Lämmle, Johanna A. Kremer Hovinga	55
13	Rumpel–Leede sign in thrombocytopenia due to Epstein–Barr virus‐induced mononucleosis 2009 ·British Journal of Haematology ·Patrick Dubach, Georgios Mantokoudis, Bernhard Lämmle	10
14	The Oklahoma Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome Registry: the Swiss connection 2008 ·European Journal Of Haematology ·James N. George, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, Bernhard Lämmle	34
15	Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13) 2008 ·Journal of Thrombosis and Haemostasis ·Armando Tripodi, Flora Peyvandi, Veena Chantarangkul, Roberta Palla, (unknown), Maria Teresa Canciani, Dominic W. Chung, Silvia Ferrari, Yoshihiro Fujimura, Mehran Karimi, Koichi Kokame, Johanna A. Kremer Hovinga, Bernhard Lämmle, Simon F. De Meyer, Barbara Plaimauer, Karen Vanhoorelbeke, Katalin Váradi, Pier Mannuccio Mannucci	38
16	The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency 2005 ·Journal of Thrombosis and Haemostasis ·Deirdra R. Terrell, Lauren A. Williams, Sara K. Vesely, Bernhard Lämmle, Johanna A. Kremer Hovinga, James N. George	231
17	Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin 2004 ·Blood ·Jan–Dirk Studt, Johanna A. Kremer Hovinga, Gerhard Antoine, Martin Hermann, Manfred Rieger, Friedrich Scheiflinger, Bernhard Lämmle	117
18	Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency 2004 ·Seminars in Hematology ·Stefano Fontana, Johanna A. Kremer Hovinga, Jan–Dirk Studt, Lorenzo Alberio, Bernhard Lämmle, Behrouz Mansouri Taleghani	29
19	ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13 2003 ·British Journal of Haematology ·Gerhard Antoine, Klaus F. Zimmermann, Barbara Plaimauer, (unknown), Jan–Dirk Studt, Bernhard Lämmle, Friedrich Scheiflinger	82
20	16 Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura 1998 ·Baillière s Clinical Haematology ·M Furlan, Bernhard Lämmle	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact